Three Arch Management IV, L.L.C.
CIK 0001365429 Name as filed on the most recent filing
Filed as Three Arch Management IV, L.L.C. (9)
42 transaction lines · from 9 filings · filed 2011-02-18 to 2015-12-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2015-12-16 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 5,066 disposed | 19.57 | 99,119.33 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-16 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 4,916 disposed | 19.57 | 96,184.49 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-16 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 265 disposed | 19.57 | 5,184.88 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-16 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 113 disposed | 19.57 | 2,210.91 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-15 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 26,697 disposed | 20.10 | 536,719.16 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-15 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 25,894 disposed | 20.10 | 520,575.57 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-15 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,392 disposed | 20.10 | 27,984.91 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-15 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 589 disposed | 20.10 | 11,841.31 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,919 disposed | 20.09 | 38,549.06 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,861 disposed | 20.09 | 37,383.95 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 100 disposed | 20.09 | 2,008.81 | Form 4, filing 0001209191-15-085648 | |
| 2015-12-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 42 disposed | 20.09 | 843.70 | Form 4, filing 0001209191-15-085648 | |
| 2015-09-10 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 58,704 disposed | 18.22 | 1,069,586.88 | Form 4, filing 0001209191-15-070494 | |
| 2015-09-10 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 56,938 disposed | 18.22 | 1,037,410.36 | Form 4, filing 0001209191-15-070494 | |
| 2015-09-10 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 3,062 disposed | 18.22 | 55,789.64 | Form 4, filing 0001209191-15-070494 | |
| 2015-09-10 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,296 disposed | 18.22 | 23,613.12 | Form 4, filing 0001209191-15-070494 | |
| 2015-08-18 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 308,195 disposed | 15.70 | 4,838,661.50 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-18 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 298,929 disposed | 15.70 | 4,693,185.30 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-18 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 16,071 disposed | 15.70 | 252,314.70 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-18 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 6,805 disposed | 15.70 | 106,838.50 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 63,596 disposed | 16.32 | 1,037,886.72 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 61,684 disposed | 16.32 | 1,006,682.88 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 3,316 disposed | 16.32 | 54,117.12 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-14 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,404 disposed | 16.32 | 22,913.28 | Form 4, filing 0001209191-15-066727 | |
| 2015-08-13 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 45,112 disposed | 16.75 | 755,626.00 | Form 4, filing 0001209191-15-066384 | |
| 2015-08-13 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 43,755 disposed | 16.75 | 732,896.25 | Form 4, filing 0001209191-15-066384 | |
| 2015-08-13 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 2,352 disposed | 16.75 | 39,396.00 | Form 4, filing 0001209191-15-066384 | |
| 2015-08-13 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 996 disposed | 16.75 | 16,683.00 | Form 4, filing 0001209191-15-066384 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 47,837 disposed | 17.49 | 836,654.78 | Form 4, filing 0001209191-15-066162 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,056 disposed | 17.49 | 18,469.12 | Form 4, filing 0001209191-15-066162 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 2,494 disposed | 17.49 | 43,619.31 | Form 4, filing 0001209191-15-066162 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 46,398 disposed | 17.49 | 811,487.10 | Form 4, filing 0001209191-15-066162 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 47,837 disposed | 14.49 | 693,143.78 | Form 4, filing 0001209191-15-066143 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 46,398 disposed | 14.49 | 672,293.10 | Form 4, filing 0001209191-15-066143 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 2,494 disposed | 14.49 | 36,137.31 | Form 4, filing 0001209191-15-066143 | |
| 2015-08-12 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 1,056 disposed | 14.49 | 15,301.12 | Form 4, filing 0001209191-15-066143 | |
| 2014-11-18 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 244,600 disposed | 12.29 | 3,006,134.00 | Form 4, filing 0001181431-14-036963 | |
| 2014-11-18 |
Concert Pharmaceuticals, Inc. CNCE |
S, Open-market sale | 5,400 disposed | 12.29 | 66,366.00 | Form 4, filing 0001181431-14-036963 | |
| 2014-02-19 |
Concert Pharmaceuticals, Inc. CNCE |
P, Open-market purchase | 101,264 acquired | 14.00 | 1,417,696.00 | Form 4, filing 0001209191-14-012994 | |
| 2014-02-19 |
Concert Pharmaceuticals, Inc. CNCE |
P, Open-market purchase | 2,236 acquired | 14.00 | 31,304.00 | Form 4, filing 0001209191-14-012994 | |
| 2011-02-16 |
Acelrx Pharmaceuticals Inc ACRX |
P, Open-market purchase | 1,261,927 acquired | 5.00 | 6,309,635.00 | Form 4, filing 0001181431-11-011594 | |
| 2011-02-16 |
Acelrx Pharmaceuticals Inc ACRX |
P, Open-market purchase | 27,863 acquired | 5.00 | 139,315.00 | Form 4, filing 0001181431-11-011594 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Three Arch Management IV, L.L.C., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001365429
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6